Price T Rowe Associates Inc Biomarin Pharmaceutical Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 663,555 shares of BMRN stock, worth $44.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
663,555
Previous 983,340 32.52%
Holding current value
$44.2 Million
Previous $81 Million 42.39%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $22.1 Million - $30 Million
-319,785 Reduced 32.52%
663,555 $46.6 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $8.86 Million - $11 Million
-118,973 Reduced 10.79%
983,340 $81 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $42.2 Million - $49.9 Million
-503,670 Reduced 31.36%
1,102,313 $96.3 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $30.6 Million - $39.5 Million
401,152 Added 33.3%
1,605,983 $155 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $7.39 Million - $8.21 Million
-86,847 Reduced 6.72%
1,204,831 $107 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $205,344 - $237,610
-2,369 Reduced 0.18%
1,291,678 $112 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $32.1 Million - $42.9 Million
366,211 Added 39.47%
1,294,047 $126 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $25.6 Million - $34.3 Million
316,129 Added 51.68%
927,836 $96 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $7.14 Million - $8.42 Million
86,888 Added 16.56%
611,707 $51.9 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $76.1 Million - $92.5 Million
-1,064,526 Reduced 66.98%
524,819 $43.5 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $27.5 Million - $34.3 Million
370,312 Added 30.38%
1,589,345 $123 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $297,351 - $379,234
4,146 Added 0.34%
1,219,033 $108 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $33.3 Million - $38.1 Million
-445,429 Reduced 26.83%
1,214,887 $93.9 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $18.9 Million - $21.2 Million
-250,194 Reduced 13.1%
1,660,316 $139 Million
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $11.5 Million - $14 Million
-154,072 Reduced 7.46%
1,910,510 $144 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $150 Million - $186 Million
2,064,582 New
2,064,582 $181 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email